Mitomycin C - Benefits, Dosage, and Side Effects

What Is Mitomycin C?

Mitomycin C is a chemotherapy drug with both antibiotic and antitumor properties. It has recently been approved for treating bladder cancer that has recurred. It is particularly used for treating a specific bladder cancer called recurrent LG IR NMIBC (low-grade intermediate-risk non-muscle invasive bladder cancer) in adult patients.

Generally, doctors may suggest you undergo surgical treatment for bladder cancer. It is often performed through a surgical procedure called TURBT (transurethral resection of bladder tumor).

But if your bladder cancer recurs even after the surgical treatment, that's when Mitomycin C will come to your rescue. In June 2025, Mitomycin C received FDA (Food and Drug Administration) approval for recurrent LG IR NMIBC.

Mitomycin C is also used to treat other cancers. However, in most cases, you can find that this drug will be given along with other anticancer medications rather than as a standalone single drug.

How Does Mitomycin C Work Against Cancer Cells?

Mitomycin C works against cancer cells by damaging and impairing their DNA (deoxyribonucleic acid). But, not exactly by the kind of damage you think. These drug molecules enter the cancer cell and, once inside, form chemical bonds between the two DNA strands.

This chemical cross-linking between the DNA strands prevents the individual strands from separating. This DNA strand separation is actually essential for a cell to multiply.

By blocking DNA strand separation, Mitomycin C eventually prevents cancer cells from multiplying and spreading. And finally, those cancer cells will lose their ability to survive.

At higher concentrations, Mitomycin C may suppress or reduce cellular RNA (ribonucleic acid) and protein production. This can make the cancer cell weak and reduce its ability to survive.

What Cancers Are Treated With Mitomycin C?

Non-muscle invasive bladder cancer recurrence, which is of low grade and with intermediate risk, is treated with Mitomycin C. Only low-grade bladder cancer that has not spread into the deeper muscular layer can be properly treated with this drug.

It may not be effective if your bladder cancer is high-grade and has already gone deeper into the bladder muscles.

Mitomycin C uses are not just restricted to bladder cancers. It has wider uses. It is especially used for the treatment of other cancers, like:

• Stomach cancers.

• Breast cancers.

• Pancreatic cancers.

• Non-small cell lung cancers.

• Anal cancers (used along with 5-Fluorouracil for anal cancer chemoradiation).

• Cervical cancers.

• Colorectal cancers.

However, the Mitomycin C dosage, formulation, and route of administration may differ when used for different cancers. It differs. Your doctor will prescribe the correct dose and form of the drug.

What Side Effects Are Associated With Mitomycin C?

The word chemotherapy might sound frightening and a bit scary to you. In fact, it's not just for you; almost everybody has this thought. You might have even seen many associating it with strong side effects.

However, intravesical Mitomycin C chemotherapy works a bit differently than your regular chemotherapy drugs. It doesn’t enter your bloodstream, so its side effects are pretty minimal.

Mitomycin C, when delivered directly into the bladder as in superficial bladder cancer treatment, commonly causes the following side effects:

• Increased creatinine.

• Increased potassium.

• Painful urination (doctors call this dysuria).

• Decreased hemoglobin.

• Increased eosinophil.

• Decreased lymphocytes.

• Decreased neutrophils.

• Increased liver enzymes.

• Presence of blood in urine (healthcare professionals name it hematuria).

• Urinary tract infections.

The abnormalities in blood cell counts are due to bone marrow toxicity. Similarly, renal toxicity also contributes to many of the side effects.

More serious side effects are also reported with this drug. Though they are pretty rare, the effects cannot be ignored and need timely medical care.

• Urinary retention.

• Narrowing of the urethra (your doctor may call it urethral stenosis).

• Cardiac failure (very rare).

The other common Mitomycin C chemotherapy side effects that you may see with almost all the drug forms of the medicine include:

• Tiredness.

• Nausea and vomiting.

• Loss of appetite.

• Bleeding tendency.

• Skin rashes.

• Weight loss.

• Headache.

How Is Mitomycin C Administered?

Mitomycin C use in bladder cancer therapy differs from its use in other cancer treatments in terms of administration technique.

For recurrent LG-IR NMIBC, the drug is administered intravesically. It means the medicine will be directly injected into your bladder rather than into your bloodstream. The administration must be continued once a week for 6 consecutive weeks.

A urinary catheter will help in delivering the medicine directly into your bladder. Intravesical administration helps the medicine reach superficial bladder cancer cells more easily. It also helps in better treatment outcomes.

For the treatment of other cancers, other than bladder cancers, it is often administered as injections through the veins (intravenous).

What Are the Benefits of Mitomycin C in Cancer Therapy?

There are several benefits that Mitomycin C chemotherapy can offer you. It is an effective treatment option for superficial bladder cancers that have recurred even after surgical therapy.

Since the medicine is administered directly into the bladder, it can directly act on the cancer cells. It is like a spot treatment, where the medicine is delivered to the area where it needs to act.

Also, this will help limit unnecessary exposure of chemotherapy drugs to other healthy organs in your body, as with intravenous injections. So that ensures not just better treatment results, but also minimal Mitomycin C side effects on other healthy organs.

It helps treat non-surgically recurrent bladder cancer. It does not require any complex procedures. Just a urinary catheter is enough to let the medicine into your bladder. This avoids the need for another surgical approach to get the recurrence out.

Mitomycin studies also showed that the treatment results are quite durable. However, the prognosis depends on how early the bladder cancer recurrence is detected and treated.

Who Should Avoid or Use Mitomycin C?

Before you start any medicine, it is very important to see if you are the right candidate for that medicine. Similarly, Mitomycin C is not for everybody with bladder cancer. Even if you have bladder cancer recurrence, only if your bladder cancer recurrence is of low grade and non-muscle invasive and of intermediate risk will doctors suggest this medicine for you.

Also, there are certain scenarios where Mitomycin C use should be avoided. If you have ever had a hypersensitivity or an allergic reaction to this medicine, then that's a red flag. You are not supposed to use this medicine. Similarly, if your bladder wall is compromised, like if you have a perforated bladder, then you cannot be considered for intravesical mitomycin C chemotherapy.

Conclusion

Mitomycin C is an antitumor antibiotic that can stop the cancer cells from spreading. It is used intravesically to treat recurrent LG IR NMIBC in adult patients. The treatment period is 6 weeks, during which the medicine will be administered once weekly. Urinary issues, renal toxicities, and bone marrow toxicities are some of its common side effects.

Mitomycin C offers a bladder-preserving, non-surgical treatment option for recurrent LG IR NMIBC. Thus, it helps reduce the need for repeated tumor resections. So if you're looking for an effective treatment to deal with your recurrent bladder cancer, consult a cancer specialist to check if Mitomycin C could be the right choice.

Key Takeaways

1. Intravesical mitomycin C chemotherapy can help you treat superficial bladder cancer recurrence.

2. It is delivered directly into the bladder, which allows targeted treatment of cancer cells.

3. Several clinical studies reported complete responses in most cases after 6 weeks of treatment.